Similar articles

• Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).

  Hedman M, Hartikainen J, Syvänne M, Stjernvall J, Hedman A, Kivelä A, Vanninen E, Mussalo H, Kauppila E, Simula S, Närvänen O, Rantala A, Peuhkurinen K, Nieminen MS, Laakso M, Ylä-Herttuala S. Hedman M, et al. Circulation. 2003 Jun 3;107(21):2677-83. doi: 10.1161/01.CIR.0000070540.80780.92. Epub 2003 May 12. Circulation. 2003. PMID: 12742981 Clinical Trial.
• Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.

  Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z. Lu D, et al. Cancer Res. 2001 Oct 1;61(19):7002-8. Cancer Res. 2001. PMID: 11585724
• Vascular endothelial growth factor gene transfer improves host endothelialization of xenogeneic biologic heart valve in vivo.

  Zhang Z, Dong H, Liu J, Wang W, Hu B. Zhang Z, et al. Chin Med J (Engl). 2002 Jun;115(6):878-83. Chin Med J (Engl). 2002. PMID: 12123557
• The biology of VEGF and its receptors.

  Ferrara N, Gerber HP, LeCouter J. Ferrara N, et al. Nat Med. 2003 Jun;9(6):669-76. doi: 10.1038/nm0603-669. Nat Med. 2003. PMID: 12778165 Review.
• Molecular and biological properties of the vascular endothelial growth factor family of proteins.

  Ferrara N, Houck K, Jakeman L, Leung DW. Ferrara N, et al. Endocr Rev. 1992 Feb;13(1):18-32. doi: 10.1210/edrv-13-1-18. Endocr Rev. 1992. PMID: 1372863 Review. No abstract available.